---
layout: default
title: "Home"
---

Welcome to my personal website.  
I'm Chris Sainsbury, and this is a minimal site built with Jekyll on GitHub Pages.

Feel free to update this text using Markdown.  
You can add additional pages by creating more Markdown files and linking to them.

2023 Clarissa Gardner, Deborah Wake, Doogie Brodie, Alex Silverstein, Sophie Young, Scott Cunningham, Chris Sainsbury, Maria Ilia, Amanda Lucas, Tony Willis, Jack Halligan. Evaluation of prototype risk prediction tools for clinicians and people living with type 2 diabetes in North West London using the think aloud method. https://doi.org/10.1177/20552076221128677

2023 A Subramanian, K Gokhale, C Sainsbury, K Nirantharakumar, KA Toulis. Sodium-glucose cotransporter-2 inhibitors and the risk of gout in patients with type 2 diabetes mellitus: A propensity-score-matched, new-user design study with an active comparator using the IQVIA Medical Research Data UK database. 2022. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.14858

2022 Risk of progression from pre‐diabetes to type 2 diabetes in a large UK adult cohort. MP Gardner, J Wang, JM Hazlehurst, C Sainsbury, J Blissett, K Nirantharakumar, N Thomas, S Bellary. 2022. Risk of progression from pre‐diabetes to type 2 diabetes in a large UK adult cohort. Diabetic medicine. https://doi.org/10.1111/dme.14996

2022 Greenwood, David, Thomas Taverner, Nicola J. Adderley, Malcolm James Price, Krishna Gokhale, Christopher Sainsbury, Suzy Gallier, et al. 2022. “Machine Learning of COVID-19 Clinical Data Identifies Population Structures with Therapeutic Potential.” iScience 25 (7): 104480.